title: Invasive fungal sinusitis in patients treated with fludarabine.
authors.forename: Tony
authors.initials: T
authors.lastname: Todd
authors.forename: Martin
authors.initials: M
authors.lastname: Besser
authors.forename: Emma
authors.initials: E
authors.lastname: Gudgin
authors.forename: Charles
authors.initials: C
authors.lastname: Crawley
authors.forename: Jenny I O
authors.initials: JI
authors.lastname: Craig
authors.forename: George
authors.initials: G
authors.lastname: Follows
authors.forename: Robert E
authors.initials: RE
authors.lastname: Marcus
authors.forename: David A
authors.initials: DA
authors.lastname: Enoch
authors.forename: James S
authors.initials: JS
authors.lastname: Cargill
authors.forename: Hugo A
authors.initials: HA
authors.lastname: Ludlam
authors.forename: Sandra Young
authors.initials: SY
authors.lastname: Min
authors.forename: Pat
authors.initials: P
authors.lastname: Sartori
mesh_terms: D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000382:microbiology*; D001231:Aspergillus flavus / Q000302:isolation & purification; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D002648:Child; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000188:drug therapy / Q000382:microbiology*; D012233:Rhizopus / Q000302:isolation & purification; D012852:Sinusitis / Q000188:drug therapy / Q000382:microbiology*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine